Weight-based Levothyroxine Dose (Adult Hypothyroidism)
Full oral replacement estimate from body weight for primary (thyroidal) hypothyroidism in adults.
Calculator
How it works
What this calculator does
It estimates a typical full replacement dose of oral levothyroxine (T4) using actual body weight. This is a starting teaching estimate used in many clinics—not a personalized prescription.
Real treatment starts lower in many patients (especially older adults or those with coronary disease), then titrates every 4–8 weeks using TSH and symptoms.
When it applies
- Adults with primary hypothyroidism where oral levothyroxine is the planned maintenance therapy.
- Teaching or bedside “ballpark” checks of whether a current or planned dose is in a plausible range.
- Not for pregnancy-specific dosing, thyroid cancer suppression goals, central hypothyroidism, or acute myxedema—those need different rules and specialist input.
Formula used here
Estimated oral T4 (mcg/day) ≈ 1.6 × weight (kg), using actual body weight.
Some references cite a similar band (often quoted ~1.5–1.7 mcg/kg/day) for full replacement in otherwise healthy adults; the calculator uses 1.6 as a single mid-range value for simplicity.
Where this comes from (references)
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. (Discusses levothyroxine therapy, monitoring with TSH, and individualized dosing.)
- Major endocrinology and clinical pharmacology sources describe weight-based full replacement in adults in roughly the 1.5–1.8 mcg/kg/day range; exact targets still depend on age, comorbidity, and TSH goal.
Why use a weight-based estimate?
- Thyroxine requirement correlates with lean mass and metabolic size; body weight is a practical proxy in adults.
- Comparing a weight-based estimate with the prescribed dose can prompt questions about adherence, malabsorption, drug interactions, or incorrect diagnosis when doses are far off.
- It helps patients and learners understand that levothyroxine doses are often much higher than typical “microgram” intuition suggests.
Important limitations
- Does not replace history, examination, TSH/free T4, cardiovascular risk, or local guidelines.
- Does not model reduced starting doses, split dosing, malabsorption syndromes, or interacting medications (iron, calcium, PPIs, etc.).
- Tablet strengths vary by country; rounding should match what is actually available to the patient.
Dosing & care
Prescribing & practical tips
- Levothyroxine tablets are marketed in many strengths (commonly including 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200, and 300 mcg). Round to a feasible tablet or combination schedule.
- If a dose falls between strengths, clinicians may use combinations, alternate-day schedules, or small weekly adjustments; T4’s long half-life tolerates modest day-to-day variation.
- Brand vs generic: many guidelines consider bioequivalence acceptable, but some patients are sensitive to formulation changes—follow local policy and patient response.
Patient-friendly use tips
- Take levothyroxine on an empty stomach with water, ideally in the morning; wait about 30–60 minutes before breakfast when possible.
- Separate calcium, iron, and some multivitamins by several hours from levothyroxine when feasible.
- Evening dosing can work if separated from food and interacting drugs—consistency matters more than clock time alone.
Follow-up (typical teaching points)
- Recheck TSH (and symptoms) roughly 4–8 weeks after a dose change in stable outpatients.
- Adjustments are often made in steps of about 12.5–25 mcg/day depending on the clinical context and how far TSH is from goal.
- Requirements far above weight-based expectations or sustained very high doses should trigger review for adherence, absorption, drug interactions, or secondary causes.
Additional clinical pearls
- Typical adult full replacement is often approximated as ~1.6 mcg/kg/day using actual body weight (literature often cites ~1.5–1.7 mcg/kg/day).
- Older adults and patients with ischemic heart disease frequently need cautious initiation and slower titration than a “full replacement estimate” implies.
- Requirements well above weight-based estimates or >200–300 mcg/day warrant evaluation for malabsorption, adherence, drug interactions, or secondary causes.
This tool is for education only. It does not establish a doctor–patient relationship, is not medical advice, and must not replace professional judgment or local guidelines. Dosing must be individualized (age, pregnancy, cardiac disease, comorbidities, TSH targets).